# TRIM9

## Overview
TRIM9 is a gene that encodes the protein tripartite motif containing 9, which is a member of the tripartite motif (TRIM) family. This family is characterized by a conserved N-terminal TRIM motif, which includes a RING domain, B-box domains, and a coiled-coil domain, all of which are essential for its function as an E3 ubiquitin ligase (Napolitano2011TRIM; Menon2015The). The TRIM9 protein is involved in various cellular processes, including synaptic function and actin dynamics, particularly during neuronal development and synaptogenesis (McCormick2024The). It also plays a role in modulating the NF-kB signaling pathway, acting as a negative regulator in the brain (Shi2014Negative). TRIM9's interactions with other proteins, such as the netrin receptor DCC and the actin polymerase VASP, are crucial for its role in synaptic responses and structure (McCormick2024The). Additionally, alterations in TRIM9 expression have been linked to various diseases, including cancer and neurological conditions, highlighting its potential as a therapeutic target (Yang2020TRIM9; Zeng2019TRIM9Mediated).

## Structure
TRIM9 is a protein that belongs to the tripartite motif (TRIM) family, characterized by a conserved N-terminal TRIM motif. This motif includes a RING domain, which is crucial for its E3 ubiquitin ligase activity, one or two B-box domains, and a coiled-coil (CC) domain that facilitates homo- and hetero-multimerization (Napolitano2011TRIM; Menon2015The). The protein also contains a COS box, a fibronectin type III (FN3) domain, and a SPRY domain (Sardiello2008Genomic). The SPRY domain is particularly significant as it directly interacts with the DCC receptor, playing a role in netrin signaling (Menon2015The).

TRIM9 has two isoforms: the long form (TRIM9l) and the short form (TRIM9s). The short isoform is involved in antiviral immunity and type I interferon signaling (Qin2016TRIM9). The COS box, adjacent to the coiled-coil domain, is essential for microtubule binding and dimerization, contributing to the protein's association with the microtubule cytoskeleton (Short2006Subclassification). TRIM9 undergoes post-translational modifications such as ubiquitination, which affects its function and localization (Menon2015The).

## Function
TRIM9 is a member of the tripartite motif (TRIM) family of proteins, functioning as an E3 ubiquitin ligase. It plays a significant role in regulating synaptic function and actin dynamics, particularly during neuronal development and synaptogenesis. TRIM9 localizes to dendritic filopodia and spines, structures crucial for neuritogenesis, axon branching, and guidance in early development, and later for dendritic spine maturation (McCormick2024The). It is involved in the maturation of dendritic filopodia into functional dendritic spines during synaptogenesis and is essential for synaptic responses to netrin-1, a guidance cue (McCormick2024The).

TRIM9 also acts as a negative regulator of the NF-kB signaling pathway, particularly in the brain. It interacts with the b-transducin repeat-containing protein (b-TrCP), a component of the SCF E3 ubiquitin ligase complex, to prevent b-TrCP from binding its substrates. This interaction stabilizes the NF-kB inhibitor IkBa and precursor p100, blocking NF-kB activation and affecting NF-kB-induced inflammatory cytokine production (Shi2014Negative). TRIM9's function as a NF-kB regulator is linked to its ability to modulate inflammatory cytokine production, such as IL-6, in response to various stimuli (Shi2014Negative).

## Clinical Significance
Alterations in TRIM9 expression have been implicated in various diseases, particularly in cancer and neurological conditions. In uterine leiomyomas, TRIM9 is overexpressed, promoting cell proliferation and reducing apoptosis through the NF-κB signaling pathway. This suggests that TRIM9 could be a potential therapeutic target for these benign tumors (Yang2020TRIM9). In bladder cancer, TRIM9 overexpression is associated with increased cell proliferation, migration, and chemoresistance, correlating with poor prognosis. The TRIM9/CEACAM6 axis activates Smad2/3 signaling, contributing to cancer progression and chemoresistance, making TRIM9 a potential prognostic biomarker and therapeutic target (Zhang2023Tripartite).

In breast cancer, TRIM9 promoter hypermethylation is common and inversely correlates with its expression. This methylation is associated with certain clinicopathological features and may serve as a biomarker for detecting circulating tumor DNA in metastatic breast cancer patients (Mishima2015Promoter).

In the context of neurological conditions, TRIM9 plays a role in neuroprotection during ischemic stroke by modulating NF-kB signaling, reducing neuroinflammation, and protecting neurons. TRIM9 deficiency leads to increased susceptibility to ischemic brain injury, highlighting its potential clinical significance in stroke treatment (Zeng2019TRIM9Mediated).

## Interactions
TRIM9 is known to participate in several protein-protein interactions that are crucial for its function in cellular processes. One significant interaction is with the b-transducin repeat-containing protein (b-TrCP), a component of the SCF E3 ubiquitin ligase complex. This interaction is phosphorylation-dependent, involving the degron motif of TRIM9, and plays a key role in inhibiting NF-kB activation by stabilizing substrates like IkBa and p100, thereby blocking both canonical and non-canonical NF-kB pathways (Shi2014Negative).

TRIM9 also interacts with the netrin receptor DCC and the actin polymerase VASP, which are part of the filopodial tip complex. These interactions are essential for synaptic responses to netrin-1 and involve nondegradative ubiquitination that alters substrate function, impacting synaptic structure and function (McCormick2024The).

In addition, TRIM9 competes with IkBa for binding to b-TrCP, influencing the ubiquitination and degradation of IkBa, which further modulates NF-kB signaling (Shi2014Negative). These interactions highlight TRIM9's role as a multidimensional regulator in both synaptic and immune signaling pathways.


## References


[1. (Mishima2015Promoter) Chieko Mishima, Naofumi Kagara, Saki Matsui, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Atsushi Shimomura, Kenzo Shimazu, Seung Jin Kim, and Shinzaburo Noguchi. Promoter methylation of trim9 as a marker for detection of circulating tumor dna in breast cancer patients. SpringerPlus, October 2015. URL: http://dx.doi.org/10.1186/s40064-015-1423-7, doi:10.1186/s40064-015-1423-7. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40064-015-1423-7)

[2. (Short2006Subclassification) Kieran M. Short and Timothy C. Cox. Subclassification of the rbcc/trim superfamily reveals a novel motif necessary for microtubule binding. Journal of Biological Chemistry, 281(13):8970–8980, March 2006. URL: http://dx.doi.org/10.1074/jbc.m512755200, doi:10.1074/jbc.m512755200. This article has 264 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m512755200)

[3. (Qin2016TRIM9) Yunfei Qin, Qingxiang Liu, Shuo Tian, Weihong Xie, Jun Cui, and Rong-Fu Wang. Trim9 short isoform preferentially promotes dna and rna virus-induced production of type i interferon by recruiting gsk3β to tbk1. Cell Research, 26(5):613–628, February 2016. URL: http://dx.doi.org/10.1038/cr.2016.27, doi:10.1038/cr.2016.27. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2016.27)

[4. (Shi2014Negative) Mude Shi, Hyelim Cho, Kyung-Soo Inn, Aerin Yang, Zhen Zhao, Qiming Liang, Gijs A. Versteeg, Samad Amini-Bavil-Olyaee, Lai-Yee Wong, Berislav V. Zlokovic, Hee-Sung Park, Adolfo García-Sastre, and Jae U. Jung. Negative regulation of nf-κb activity by brain-specific tripartite motif protein 9. Nature Communications, September 2014. URL: http://dx.doi.org/10.1038/ncomms5820, doi:10.1038/ncomms5820. This article has 64 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms5820)

[5. (Sardiello2008Genomic) Marco Sardiello, Stefano Cairo, Bianca Fontanella, Andrea Ballabio, and Germana Meroni. Genomic analysis of the trim family reveals two groups of genes with distinct evolutionary properties. BMC Evolutionary Biology, August 2008. URL: http://dx.doi.org/10.1186/1471-2148-8-225, doi:10.1186/1471-2148-8-225. This article has 220 citations.](https://doi.org/10.1186/1471-2148-8-225)

[6. (Zeng2019TRIM9Mediated) Jianxiong Zeng, Yaoming Wang, Zhifei Luo, Lin-Chun Chang, Ji Seung Yoo, Huan Yan, Younho Choi, Xiaochun Xie, Benjamin E. Deverman, Viviana Gradinaru, Stephanie L. Gupton, Berislav V. Zlokovic, Zhen Zhao, and Jae U. Jung. Trim9-mediated resolution of neuroinflammation confers neuroprotection upon ischemic stroke in mice. Cell Reports, 27(2):549-560.e6, April 2019. URL: http://dx.doi.org/10.1016/j.celrep.2018.12.055, doi:10.1016/j.celrep.2018.12.055. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2018.12.055)

[7. (Menon2015The) Shalini Menon, Nicholas Patrick Boyer, Cortney Chelise Winkle, Leslie Marie McClain, Christopher Carey Hanlin, Dharmendra Pandey, Simon Rothenfußer, Anne Marion Taylor, and Stephanie Lynn Gupton. The e3 ubiquitin ligase trim9 is a filopodia off switch required for netrin-dependent axon guidance. Developmental Cell, 35(6):698–712, December 2015. URL: http://dx.doi.org/10.1016/j.devcel.2015.11.022, doi:10.1016/j.devcel.2015.11.022. This article has 77 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.devcel.2015.11.022)

[8. (Zhang2023Tripartite) Zhao-Cun Zhang, Hai-Feng Zhao, Zhuang Sun, Yi Li, Ming-Lei Zhong, Bao-Hai Wang, and Xian-Zhou Jiang. Tripartite motif–containing 9 promoted proliferation and migration of bladder cancer cells through ceacam6-smad2/3 axis. Journal of Cell Communication and Signaling, 17(4):1323–1333, May 2023. URL: http://dx.doi.org/10.1007/s12079-023-00766-7, doi:10.1007/s12079-023-00766-7. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12079-023-00766-7)

[9. (Napolitano2011TRIM) Luisa M. Napolitano and Germana Meroni. Trim family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life, 64(1):64–71, November 2011. URL: http://dx.doi.org/10.1002/iub.580, doi:10.1002/iub.580. This article has 142 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/iub.580)

[10. (Yang2020TRIM9) Fang Yang, Hong Liu, Yonghui Yu, and Lin Xu. Trim9 overexpression promotes uterine leiomyoma cell proliferation and inhibits cell apoptosis via nf-κb signaling pathway. Life Sciences, 257:118101, September 2020. URL: http://dx.doi.org/10.1016/j.lfs.2020.118101, doi:10.1016/j.lfs.2020.118101. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.lfs.2020.118101)

11. (McCormick2024The) The E3 ubiquitin ligase TRIM9 regulates synaptic function and actin dynamics. This article has 1 citations.